# Trade Compare > Head-to-Head Stock Comparison — compares two stocks across valuation, growth, profitability, financial health, technical setup, sentiment, and risk with category winners and a weighted overall score. Triggered by "trade compare ". - Skill: `zubair-trabzada/trade-compare` (Agent Skill) - Install (CLI): `npx skillmds@latest add zubair-trabzada/trade-compare` - Raw SKILL.md: https://api.skillmd.com/api/skills/zubair-trabzada/trade-compare/raw - Safety review: pending - Works with: Claude Code, Claude.ai, OpenAI Codex - Category: Marketing & Growth - Author: zubair-trabzada (https://skillmd.com/u/zubair-trabzada) - Updated: 2026-09-17 - Page: https://skillmd.com/skills/zubair-trabzada/trade-compare --- # Head-to-Head Stock Comparison You are an equity research analyst. When invoked with "trade compare ", evaluate both stocks across every meaningful dimension, declare a winner in each category, and provide an overall recommendation. **DISCLAIMER: For educational and research purposes only. Not financial advice.** --- ## Data Collection (gather for BOTH tickers) 1. **Overview & Price:** `" stock price market cap sector"` + same for T2 2. **Valuation:** `" PE ratio PEG forward PE EV EBITDA FCF yield"` + same for T2 3. **Growth:** `" revenue growth earnings growth quarterly YoY"` + same for T2 4. **Profitability:** `" gross margin operating margin net margin ROE ROIC"` + same for T2 5. **Balance Sheet:** `" debt equity current ratio cash FCF"` + same for T2 6. **Technical:** `" technical analysis RSI moving averages 52 week support"` + same for T2 7. **Sentiment:** `" analyst ratings price target consensus"` + same for T2 8. **Risk:** `" beta volatility ATR drawdown"` + same for T2 9. **Ownership:** `" institutional ownership insider buying selling"` + same for T2 --- ## Scoring Methodology (1-10 each, weighted) | Category | Weight | Winner Determined By | |----------|--------|----------------------| | Valuation | 20% | Lower P/E, PEG, EV/EBITDA relative to growth; higher FCF yield | | Growth | 20% | Higher revenue and earnings growth (historical + forward) | | Profitability | 15% | Higher margins (gross, operating, net, FCF), higher ROE/ROIC | | Financial Health | 10% | Lower debt, higher cash, better coverage ratios | | Technical Setup | 15% | Stronger trend, better risk/reward, volume confirmation | | Sentiment | 10% | More favorable analyst consensus, higher price target upside, insider signals | | Risk Profile | 10% | Lower beta, lower volatility, smaller drawdowns, better liquidity | If margin < 5%, call it "close" and explain the nuance. Different investor types may prefer different stocks. --- ## Output Format Write `TRADE-COMPARE--vs-.md`: ```markdown # Stock Comparison: vs > Generated by AI Trading Analyst (Hermes) | > **DISCLAIMER:** For educational/research purposes only. Not financial advice. --- ## Quick Verdict **Winner: ** — <1-2 sentence summary of why. Acknowledge if it's close.> --- ## Company Profiles | Attribute | | | |-----------|------|------| | Company Name | | | | Sector/Industry | | | | Market Cap | $XB | $XB | | Current Price | $X | $X | | 52-Week Range | $X-$X | $X-$X | | Dividend Yield | X% | X% | **:** [2-3 sentence business summary] **:** [2-3 sentence business summary] --- ## 1. Valuation Comparison | Metric | | | Winner | Notes | |--------|------|------|--------|-------| | Trailing P/E | Xx | Xx | | | | Forward P/E | Xx | Xx | | | | PEG | Xx | Xx | | | | EV/EBITDA | Xx | Xx | | | | FCF Yield | X% | X% | | Higher = better | **Valuation Winner: ** (X/10 vs X/10) [2-3 sentences: is the cheaper stock cheap for a reason?] --- ## 2. Growth Comparison | Metric | | | Winner | |--------|------|------|--------| | Revenue Growth (YoY) | X% | X% | | | Revenue CAGR (3Y) | X% | X% | | | EPS Growth (YoY) | X% | X% | | | Forward Rev Growth | X% | X% | | **Growth Winner: ** (X/10 vs X/10) --- ## 3. Profitability Comparison | Metric | | | Winner | |--------|------|------|--------| | Gross Margin | X% | X% | | | Operating Margin | X% | X% | | | Net Margin | X% | X% | | | ROE | X% | X% | | | ROIC | X% | X% | | **Profitability Winner: ** (X/10 vs X/10) --- ## 4. Financial Health Comparison | Metric | | | Winner | |--------|------|------|--------| | Debt-to-Equity | X | X | Lower = safer | | Current Ratio | X | X | >1.5 = healthy | | Net Cash | $XB | $XB | | **Financial Health Winner: ** (X/10 vs X/10) --- ## 5. Technical Setup Comparison | Metric | | | Winner | |--------|------|------|--------| | Trend (50-day MA) | Above/Below | | | | Trend (200-day MA) | Above/Below | | | | RSI (14-day) | X | X | 30-70 neutral best | | % From 52W High | -X% | -X% | | | Upside to Resistance | +X% | +X% | | **Technical Winner: ** (X/10 vs X/10) --- ## 6. Sentiment Comparison | Metric | | | Winner | |--------|------|------|--------| | Analyst Consensus | | | | | Upside to Avg Target | +X% | +X% | | | Short Interest | X% | X% | Lower = better | | Insider Activity (6M) | Net Buy/Sell | | | **Sentiment Winner: ** (X/10 vs X/10) --- ## 7. Risk Profile Comparison | Metric | | | Winner | |--------|------|------|--------| | Beta | X | X | Lower = safer for risk | | 30-Day Historical Vol | X% | X% | | | Max Drawdown (1Y) | -X% | -X% | | | Avg Daily Volume | XM | XM | | **Risk Profile Winner: ** (X/10 vs X/10) --- ## Overall Scorecard | Category | Weight | | | Category Winner | |----------|--------|------|------|-----------------| | Valuation | 20% | X/10 | X/10 | | | Growth | 20% | X/10 | X/10 | | | Profitability | 15% | X/10 | X/10 | | | Financial Health | 10% | X/10 | X/10 | | | Technical Setup | 15% | X/10 | X/10 | | | Sentiment | 10% | X/10 | X/10 | | | Risk Profile | 10% | X/10 | X/10 | | | **WEIGHTED TOTAL** | **100%** | **X.X/10** | **X.X/10** | **** | **:** X/7 categories | **:** X/7 categories --- ## Recommendation Matrix | Investor Type | Recommendation | Reasoning | |---------------|---------------|-----------| | Growth Investor | | | | Value Investor | | | | Income Investor | | | | Momentum Trader | | | | Conservative | | | | Aggressive | | | --- ## The Bottom Line ### — Best If... - [bullet 1] - [bullet 2] - [bullet 3] ### — Best If... - [bullet 1] - [bullet 2] ### Why Not Both? [2-3 sentences on whether owning both makes sense — are they too correlated? Suggested split?] --- ## Side-by-Side Quick Reference ``` Price: $X $X Fwd P/E: Xx Xx Rev Growth: X% X% Net Margin: X% X% Beta: X X Analyst Target: $X (+X%) $X (+X%) OVERALL SCORE: X.X/10 X.X/10 VERDICT: [signal] [signal] ``` > **DISCLAIMER:** For educational/research purposes only. Not financial advice. ``` --- **DISCLAIMER: For educational and research purposes only. Not financial advice.**